1 month ago

GLP-1 drugs linked to higher hair loss risk

GLP-1 drugs linked to higher hair loss risk
Hair loss risk up by 68 per cent? New study puts GLP-1 drugs under the spotlight · easterneye.biz

A new study found that people taking GLP-1 drugs like Ozempic, Wegovy, and Mounjaro might have a higher chance of losing their hair.

The study looked at health records of about 50,000 adults and found that those on GLP-1 drugs had a 37% higher risk of hair loss compared to people taking other diabetes medicines, and a 68% higher risk compared to another group.

Health regulators in the UK and US have received many reports of hair loss linked to these drugs.

Experts think the rapid weight loss caused by these drugs might be the main reason for hair loss, as it can lead to a lack of important nutrients like iron, zinc, and biotin.

However, more research is needed to confirm if the drugs themselves cause hair loss or if it's mainly due to the weight loss.

Hair loss might not be physically harmful, but it can affect how people feel about themselves and their quality of life.

Key facts

Study Source
British Medical Journal (BMJ)
Sample Size
Around 50,000 adults
Higher Risk Compared to SGLT-2 Inhibitors
37%
Higher Risk Compared to DPP-4 Inhibitors
68%
UK Reports of Hair Loss (2026)
400 reports for tirzepatide, 148 reports for semaglutide
US Regulatory Review
Ongoing evaluation by the FDA
Potential Nutrient Deficiencies
Iron, zinc, and biotin

Quotes

Researchers from the University of Pennsylvania

University of Pennsylvania researchers

“"Hair loss may not cause physical harm, but it can have 'significant psychosocial consequences'"”
easterneye.biz

Sources

Related news